{"name":"Elios Therapeutics, LLC","slug":"elios-therapeutics-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxQT195Um84VEw5TDFnZ0x5N0VydUJ0aDNTVGF1SDVWdjh0bEFwbEtyZzM4R2ZEbENDdTVwQzJSV0ZrUU9JSlVZbTZ5TXlYd3NyYmpXT3pVMzdEUHRuTi1lYURucmpkR2M4bzJTeTFNU05iM3dIX0JNNzdoT1otUWVoT3VZamZrTzA5bmYxaUxmTEMxZVpuWm5aRFlVdmZWeXRxU2lWclBRLXg0eEZndGl6VkxBUGRYWjFHdHp0bU9jdnQ1SmpfLXlOd3dPTkhSMTJPRHdDZlpfMjdHQjNyR21Zd2pnU21aQTNOam1SZUw5ZkNyb19xOUMyc0pxRnl4Z2hnRHdLc19CTkdQSy1EYTdDTFRuYkZYRHE0S2tFYm1TMVI?oc=5","date":"2025-10-14","type":"trial","source":"globenewswire.com","summary":"Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma - globenewswire.com","headline":"Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE5qRU4yRk9GN2pyTWVnNnQwbEdIQzNpb2JCZ3lQX041d1NsS29CaGRBRGZqMURTQzAwdTQ1Nzl4ZGVaNHNxSk9rX0pwMTdOV1FyRG9uUl9tQkl6ci1BSUN5N3o4enBtZHJJblFSYnpDbDQtQQ?oc=5","date":"2024-06-30","type":"pipeline","source":"The Pharma Letter","summary":"Elios Therapeutics - The Pharma Letter","headline":"Elios Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOcjRBbVBRTkFIVHF1V3FLUTRpZFNKb1dxR2E5S3MzWHJaSG9tY0lHNGVsMzJCZ2JkalFrM3VwX1lfRGY4ZzdELVR3VWxKcWpXQUVTamk3NU5VRndOT0VpOUk3dVVFOHBTWF9CWWFHTWdsSk40Z21uQzYzOUNGMTZmVmlSTm9WVlFDbElJcUphaVZoTExORDNPTXMyMTAtaGZvMUpJdUZXNG1qZjV2Wk40S1BHdzFqNEpqZEpzeTJ6dk9YNGpsVGc3WDZleFJ3LTZsNnMwZ2FOTEFqa29fVV9RVGhqMlNNWDNSMkxGTU9HZklMeW8?oc=5","date":"2022-02-10","type":"pipeline","source":"PR Newswire","summary":"Elios Therapeutics Announces the Appointment of Mark H.N. Corrigan, M.D. as Chairman of the Board of Directors - PR Newswire","headline":"Elios Therapeutics Announces the Appointment of Mark H.N. Corrigan, M.D. as Chairman of the Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQYnI3SnFHRHFWVG1wdXplMmZJaEtLWHFmSWszX0FrMU4xSFM0LWVYSzZacmlOUGxxRHZPOWZLWXctZzMxUWdVN1BGdUZmMmVtVUpqcDRiZC0xVjlyaHlVYnFtcmR4ZTkyTHNSaUs5OXd1djFYZjNOWG9fRDRjYmwwY2ZEZGRIVHlOSkZkanpNcTM0LVE2V1p6VjM3b2djbkMxR3pVZzgyT04zcVRkNlNoZU1JSE1PQlczcDN0enp6TVBtdHJ3ajRPZVR0V2ZJYk0xNGt5Vk1STWpUcHlzOWJNYmp2Z2ZkMWlaWmQ0dF93TjJmNUctVW9r?oc=5","date":"2021-09-29","type":"pipeline","source":"PR Newswire","summary":"Elios Therapeutics Strengthens Board of Directors with Appointment of Key Financial Executive Michael Caprio - PR Newswire","headline":"Elios Therapeutics Strengthens Board of Directors with Appointment of Key Financial Executive Michael Caprio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxPTnNSLWprd25YcWk5Zzg2Mi1Bc3B6WWN5LWdIbW1EMHBNam5DSnlLbXljRER4cjAwYTJMT1hQbWtfdi1RMGJuQ1FGcENlNDlWdjJoaURBcmpTbXBLbEFVUUFLZHN2VGtxb05LaHhOYUNnOUYzRm9TVEVJbjRic0Npd0VDR0Z4NUk2cTU5cHhyclYwVWYzVUFYaUNTYkwxRjJtTUNSbFFNdWoyNEZxVVAwT0Y4V1dkOW5RUGxkUHFPMmo2R2wwVjJ5blJ1Umt5SVB0SEg5Nlk5dFB4ZENiS3h6MkZYZW5mTHdIVWptRFByZ3A0cnE5WU1NRUNXMkNlaHp6Z1JfMVV0TVZGU2s?oc=5","date":"2020-10-20","type":"pipeline","source":"PR Newswire","summary":"Perseus Holdings USA Strengthens Board of Directors with Appointment of Veteran Biotechnology Executive Mark H.N. Corrigan, M.D. - PR Newswire","headline":"Perseus Holdings USA Strengthens Board of Directors with Appointment of Veteran Biotechnology Executive Mark H.N. Corrig","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxOQ2lqRW1iWFdfQnRiUzV4Z0NlTTcydDRycElpNFNITS1xYnBoUGdJLWxXbWFuV01waEdTVkNWQzB5WFhGRmoyQWtUWTdKUUFxTWZYS09zek1rUnJvNUF5SFpnT3JHNkRXMGlreDQ1cXlqY2xYbDFRdmNFamdKZTVSVmZTcDhzX3QxaE1QaHdUUFQ3bGJwaXd4eUU4azIzWlpQRUxCN2VtR25jTnZ5a2NiNXotUWhEbDlmZHhUUEVmRkwybkVyTnhwdXpjci1YZm5mOEQwMFMwcWV5VTdiSHFlSWc4dVM0cGNRWjJ2dG1ockdPM2tYSWN6dTdHblVSUHpEUU5JR0FWaXRLUDhBVDAyOFpZZEpGNy1DRU1Fb1FEWDJCVXJFekZGRlA4VG0?oc=5","date":"2020-08-05","type":"trial","source":"PR Newswire","summary":"Elios Therapeutics Personalized Cancer Vaccine Demonstrates Long-Term Survival Benefit Among High-Risk Melanoma Patients in Phase IIb Final Analysis - PR Newswire","headline":"Elios Therapeutics Personalized Cancer Vaccine Demonstrates Long-Term Survival Benefit Among High-Risk Melanoma Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxNdDNWMU1lWVFsMmhta29pMVUxdzBnWDJzVElwNzNLMDBCdm5mMmpUWVVQM3FpM05JRGR0Sm45VUZnYnVRVFZKOGQyNHRnRzR3ZFh5c0hLVmNtTG9oS2VkTzQ4QWk4M3hSWlAxeEhJc1ZiTi1LZnRtTWwyOGR0SWV2YUxHZUVDYkRmeXJzcWd1ZzVWdkJBSURIdThacllCbmpYdGhCbnEybS16Z3o4a3dxeUJGR184SHFQTXV3ZVljYnVxN0FEOUpoSXRHbldnUVFIR3BKdVpTYjFKNEhQZUlSSWg3UElWLVB0dUhOTkh6b0l0anJ0M3B1Zi1RTjlmU1NtOEJLN2JiYWJwaWNJbzQzYVg1YzhvTENVdTVhNzJ3?oc=5","date":"2019-07-17","type":"trial","source":"BioSpace","summary":"Elios Therapeutics Announces Positive Top-Line Data from Phase IIb Study Evaluating TLPLDC, a Personalized Therapeutic Cancer Vaccine, in Patients with High-Risk Melanoma - BioSpace","headline":"Elios Therapeutics Announces Positive Top-Line Data from Phase IIb Study Evaluating TLPLDC, a Personalized Therapeutic C","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}